2284 related articles for article (PubMed ID: 27733666)
1. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of electronic health record implementation on pharmacist interventions related to oral chemotherapy management.
Finn A; Bondarenka C; Edwards K; Hartwell R; Letton C; Perez A
J Oncol Pharm Pract; 2017 Dec; 23(8):563-574. PubMed ID: 27573921
[TBL] [Abstract][Full Text] [Related]
3. Physician-pharmacist collaboration for oral chemotherapy monitoring: Insights from an academic genitourinary oncology practice.
Holle LM; Puri S; Clement JM
J Oncol Pharm Pract; 2016 Jun; 22(3):511-6. PubMed ID: 25900102
[TBL] [Abstract][Full Text] [Related]
4. A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.
Jackson K; Letton C; Maldonado A; Bodiford A; Sion A; Hartwell R; Graham A; Bondarenka C; Uber L
J Oncol Pharm Pract; 2019 Jun; 25(4):847-854. PubMed ID: 29587608
[TBL] [Abstract][Full Text] [Related]
5. Implementing an opioid risk assessment telephone clinic: Outcomes from a pharmacist-led initiative in a large Veterans Health Administration primary care clinic, December 15, 2014-March 31, 2015.
Jacobs SC; Son EK; Tat C; Chiao P; Dulay M; Ludwig A
Subst Abus; 2016; 37(1):15-9. PubMed ID: 26675444
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction.
Ribed A; Romero-Jiménez RM; Escudero-Vilaplana V; Iglesias-Peinado I; Herranz-Alonso A; Codina C; Sanjurjo-Sáez M
Int J Clin Pharm; 2016 Apr; 38(2):280-8. PubMed ID: 26715547
[TBL] [Abstract][Full Text] [Related]
7. Initial experience with antiarrhythmic medication monitoring by clinical pharmacists in an outpatient setting: a retrospective review.
Snider M; Kalbfleisch S; Carnes CA
Clin Ther; 2009 Jun; 31(6):1209-18. PubMed ID: 19695388
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of patient and provider satisfaction with a pharmacist-managed lipid clinic in a Veterans Affairs medical center.
Collins C; Kramer A; O'Day ME; Low MB
Am J Health Syst Pharm; 2006 Sep; 63(18):1723-7. PubMed ID: 16960256
[TBL] [Abstract][Full Text] [Related]
9. Guiding pharmacist clinical interviews: a safety tool to support the education of patients treated with oral antineoplastic agents.
Ribed A; Escudero-Vilaplana V; Romero-Jimenez RM; Iglesias-Peinado I; Herranz-Alonso A; Sanjurjo-Saez M
Expert Opin Drug Saf; 2016; 15(4):427-35. PubMed ID: 26854363
[TBL] [Abstract][Full Text] [Related]
10. Retrospective evaluation of medication appropriateness and clinical pharmacist drug therapy recommendations for home-based primary care veterans.
Davis RG; Hepfinger CA; Sauer KA; Wilhardt MS
Am J Geriatr Pharmacother; 2007 Mar; 5(1):40-7. PubMed ID: 17608246
[TBL] [Abstract][Full Text] [Related]
11. Impact of a formal pharmacist-run oral antineoplastic monitoring program: A pilot study in an adult genitourinary oncology clinic.
Conliffe B; Figg L; Moffett P; Lauterwasser L; Parsons LB
J Oncol Pharm Pract; 2019 Jun; 25(4):777-786. PubMed ID: 29375014
[TBL] [Abstract][Full Text] [Related]
12. Impact of oncology pharmacist-managed oral anticancer therapy in patients with chronic myelogenous leukemia.
Lam MS; Cheung N
J Oncol Pharm Pract; 2016 Dec; 22(6):741-748. PubMed ID: 26419691
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Economic Effects of a Pharmacist-Administered Antiretroviral Therapy Adherence Clinic for Patients Living with HIV.
Dilworth TJ; Klein PW; Mercier RC; Borrego ME; Jakeman B; Pinkerton SD
J Manag Care Spec Pharm; 2018 Feb; 24(2):165-172. PubMed ID: 29384024
[TBL] [Abstract][Full Text] [Related]
14. E-prescribing errors identified in a compounding pharmacy: a quality-improvement project.
Reed-Kane D; Kittell K; Adkins J; Flocks S; Nguyen T
Int J Pharm Compd; 2014; 18(1):83-6. PubMed ID: 24881345
[TBL] [Abstract][Full Text] [Related]
15. Improved Adherence Rates and Clinical Outcomes of an Integrated, Closed-Loop, Pharmacist-Led Oral Chemotherapy Management Program.
Muluneh B; Schneider M; Faso A; Amerine L; Daniels R; Crisp B; Valgus J; Savage S
J Oncol Pract; 2018 Jun; 14(6):e324-e334. PubMed ID: 29799768
[TBL] [Abstract][Full Text] [Related]
16. Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.
Tasaka Y; Yasunaga D; Tanaka M; Tanaka A; Asakawa T; Horio I; Miyauchi Y; Araki H
Int J Clin Pharm; 2016 Apr; 38(2):321-9. PubMed ID: 26744362
[TBL] [Abstract][Full Text] [Related]
17. Implementation and outcomes of a pharmacist-led oral chemotherapy clinic at VA Maine Healthcare System.
Sargent W; Whalley A
J Oncol Pharm Pract; 2022 Dec; 28(8):1704-1708. PubMed ID: 34569884
[TBL] [Abstract][Full Text] [Related]
18. Assessing the effect of providing a pharmacist with patient diagnosis on electronic prescription orders: a pilot study.
Warholak TL; Rupp MT; Leal S; Kurniawan G; Patel N
Res Social Adm Pharm; 2014; 10(1):246-51. PubMed ID: 23688539
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a pharmacist-led outpatient direct oral anticoagulant service.
Ashjian E; Kurtz B; Renner E; Yeshe R; Barnes GD
Am J Health Syst Pharm; 2017 Apr; 74(7):483-489. PubMed ID: 28336758
[TBL] [Abstract][Full Text] [Related]
20. Evaluation and implementation of chemotherapy regimen validation in an electronic health record.
Diaz AH; Bubalo JS
J Oncol Pharm Pract; 2014 Dec; 20(6):461-8. PubMed ID: 24500809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]